Author： Thomas S.M. Brady M. Burke J.F.
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.12, 1997-12, pp. : 1393-1400
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Merck: the scattering of DNA sequence patents
By Thomas S.M. Brady M. Burke J.F.
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 12, 1998-12 ,pp. :
Access to resources
Recommend
The end of DNA patents in the United States?
Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. :
Sequence Recognition of DNA by Lexitropsins
Current Medicinal Chemistry, Vol. 8, Iss. 5, 2000-05 ,pp. :
Roche’s DNA patents: a major push in diagnostics?
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 1, 1998-01 ,pp. :